Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - vaccination
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Prefusion Coronavirus Spike Proteins and Their Use
Coronaviruses (CoVs) can cause severe respiratory disease with high fatality rates in humans. The 2002-2003 SARS-CoV epidemic resulted in 8098 cases and 744 deaths, and MERS-CoV, which emerged in 2012, has resulted in 2144 cases and over 750 deaths as of March 2018. Currently, there are no effective prophylactic or therapeutic measures, and because...
Published: 10/28/2024
|
Inventor(s):
Masaru Kanekiyo
,
Michael Joyce
,
Kizzmekia Corbett
,
Hadi Yassine
,
Jason McLellan
,
Christopher Cottrell
,
Nianshuang Wang
,
Jesper Pallesen
,
Hannah Turner
,
Robert Kirchdoerfer
,
Andrew Ward
,
Barney Graham
Keywords(s):
CORONAVIRUS
,
DC5BXX
,
proteins
,
Stabilized
,
VACCINATION
Category(s):
Collaboration Sought > Collaboration
,
TherapeuticArea > Infectious Disease
,
Application > Vaccines
AMA1-RON2 Complex-Based Vaccine Against Malaria
This technology relates to a malaria vaccine composed of a protein complex of Apical Membrane Antigen (AMA1) and rhoptry neck protein 2 (RON2) with an adjuvant. AMA1 is a crucial component of the Plasmodium invasion machinery and is a leading candidate for antimalarial vaccine development. AMA1-based vaccines have shown ability to block red cell invasion...
Published: 10/28/2024
|
Inventor(s):
Louis Miller
,
Prakash Srinivasan
Keywords(s):
Against
,
AMAI-RON2
,
CHALLENGE
,
COMPLEX
,
DC2XXX
,
Lethal
,
PLASMODIUM
,
Protection
,
PROVIDES
,
VACCINATION
Category(s):
Collaboration Sought > Collaboration
,
TherapeuticArea > Infectious Disease
,
Application > Vaccines
Intranasal Dry Powder Inhaler for Improved Delivery of Vaccines and Therapeutics
This Intranasal Dry Powder Inhaler (DPI), developed with Creare, Inc., allows low-cost delivery of powder vaccines. Nasal delivery has numerous advantages compared to traditional injected vaccines, including: 1) safe, needle-less administration by minimally-trained staff or patient; 2) better protection due to mucosal and cross-protection; and 3) decreased...
Published: 10/28/2024
|
Inventor(s):
James Barry
,
Darin Knaus
,
Edward Moynihan
,
Eric Friets
,
Mark Bagley
,
Mark Papania
Keywords(s):
AB1XXX
,
AB3FXX
,
AB3GXX
,
ABXXXX
,
Agents
,
AXXXXX
,
BACTERIA
,
Bacterial
,
BACTERIAL VACCINES
,
Biodefense
,
biosecurity
,
bioterrorism
,
Bioterrorist
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
Child safety device
,
CHILDHOOD
,
Children
,
DB1XXX
,
DB2XXX
,
DB3XXX
,
DB4AXX
,
DB4BXX
,
DB4XXX
,
DB5XXX
,
DBXXXX
,
DC1XXX
,
DC2XXX
,
DC3XXX
,
DC4XXX
,
DC5XXX
,
DC6XXX
,
DCXXXX
,
Delivery
,
delivery system
,
DEVELOPED
,
DEVELOPING
,
DEVICE
,
Devices
,
Disposable
,
DISPOSAL
,
Dry
,
DXXXXX
,
Field
,
Field-usable
,
FUNGAL
,
Intranasal
,
MEASLES
,
NASAL
,
Needle
,
OID-NCIRD-DVD
,
Portable
,
POWDER
,
Prevention
,
respiratory
,
SAFETY
,
SELF-ADMINISTRATION
,
Single-use
,
System
,
therapeutic delivery
,
treatment
,
VACCINATION
,
Vaccination
s
,
VACCINE DELIVERY
,
vaccines
,
VBXXXX
,
viral vaccine
,
VJXXXX
,
VKXXXX
,
VLXXXX
,
VOXXXX
,
WAXXXX
,
WKXXXX
,
WMXXXX
,
XDXXXX
,
YBXXXX
,
YFXXXX
Category(s):
Collaboration Sought > Licensing
,
Application > Diagnostics
,
Application > Medical Devices
,
Application > Vaccines
,
TherapeuticArea > Infectious Disease
,
Application > Non-Medical Devices
,
Application > Consumer Products
,
Application > Therapeutics